We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$18.3B
AUM Growth
+$1.38B
Cap. Flow
-$639M
Cap. Flow %
-3.49%
Top 10 Hldgs %
37.51%
Holding
256
New
14
Increased
34
Reduced
47
Closed
63

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$418M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$235M
3
EXEL icon
Exelixis
EXEL
+$219M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$191M
5
SJR
Shaw Communications Inc.
SJR
+$183M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$152M
2
CLVT icon
Clarivate
CLVT
+$127M
3
SGFY
Signify Health, Inc.
SGFY
+$113M
4
LHCG
LHC Group LLC
LHCG
+$111M
5
ATVI
Activision Blizzard
ATVI
+$87M

Sector Composition

Rank Sector Weight
1 Healthcare 33.33%
2 Technology 18.46%
3 Financials 12.48%
4 Industrials 7.09%
5 Communication Services 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCFA
101
DELISTED
Perception Capital Corp. IV
RCFA
$6.28M 0.03%
600,000
– –
VYGR icon
102
Voyager Therapeutics
VYGR
$201M
$6.14M 0.03%
+797,000
New +$6.34M
SLAM
103
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$5.89M 0.03%
570,396
– –
VNET
104
VNET Group
VNET
$2.09B
$5.75M 0.03%
1,775,000
– –
BWC
105
DELISTED
Blue Whale Acquisition Corp I Class A Ordinary Shares
BWC
$5.72M 0.03%
575,000
– –
ICE icon
106
Intercontinental Exchange
ICE
$84.4B
$5.41M 0.03%
+51,832
New +$5.4M
LBPH
107
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$5.29M 0.03%
1,560,500
+750,000
+93% +$3.66M
TIOA
108
DELISTED
Tio Tech A Class A Ordinary Share
TIOA
$5.11M 0.03%
502,001
– –
GHIX
109
DELISTED
Gores Holdings IX, Inc. Class A Common Stock
GHIX
$5.04M 0.03%
500,000
– –
ATTO
110
DELISTED
Atento S.A.
ATTO
$4.64M 0.03%
2,230,357
– –
LGVC
111
DELISTED
LAMF Global Ventures Corp. I Class A Ordinary Shares
LGVC
$4.18M 0.02%
400,000
– –
FSRX
112
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
$4.04M 0.02%
400,000
-200,000
-33% -$2.03M
FRXB
113
DELISTED
Forest Road Acquisition Corp. II
FRXB
$3.98M 0.02%
400,000
-850,000
-68% -$8.55M
CITE
114
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
$3.69M 0.02%
350,000
– –
VMGA
115
DELISTED
VMG Consumer Acquisition Corp. Class A Common Stock
VMGA
$3.63M 0.02%
350,000
– –
UTAA
116
DELISTED
UTA Acquisition Corporation Class A Ordinary Shares
UTAA
$3.58M 0.02%
344,100
– –
AMAM
117
DELISTED
Ambrx Biopharma Inc
AMAM
$3.22M 0.02%
+361,000
New +$1.81M
SPCM
118
DELISTED
Sound Point Acquisition Corp I, Ltd Class A Ordinary Share
SPCM
$3.17M 0.02%
300,000
– –
TECX
119
Tectonic Therapeutic
TECX
$606M
$3.12M 0.02%
259,667
+198,000
+321% +$2.76M
NUVB icon
120
Nuvation Bio
NUVB
$2.32B
$2.43M 0.01%
1,465,000
-652,600
-31% -$1.32M
PRVB
121
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$2.17M 0.01%
+90,000
New +$1.13M
ARYD
122
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$2.06M 0.01%
200,000
-600,000
-75% -$6.12M
GATE
123
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
$1.51M 0.01%
150,000
– –
ALNY icon
124
Alnylam Pharmaceuticals
ALNY
$29.3B
$1.35M 0.01%
6,719
-123,337
-95% -$25.9M
BPMC
125
DELISTED
Blueprint Medicines
BPMC
$1.01M 0.01%
22,420
-71,580
-76% -$3.22M
3 4
5
6 7

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Farallon Capital Management held 256 positions worth $18.3B, up 8.2% from $16.9B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Farallon Capital Management withdrew a net $639M in Q1 2023, closing 63 positions and reducing 47 holdings. Its most notable exit was AbbVie, an estimated $152M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in UnitedHealth worth $409M.

  • Farallon Capital Management's largest Q1 2023 buy was UnitedHealth: 866,000 shares worth $409M.
  • Farallon Capital Management added most to Alphabet (Google) Class C in Q1 2023, an estimated $235M increase.
  • Farallon Capital Management's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $87M.
  • Farallon Capital Management fully exited AbbVie in Q1 2023, selling an estimated $152M.
  • Farallon Capital Management's ten largest holdings make up 38% of its $18.3B portfolio in Q1 2023.
  • Farallon Capital Management opened 14 new positions and closed 63 in Q1 2023.
  • Farallon Capital Management's portfolio value rose 8.2% quarter-over-quarter to $18.3B.

Based on Farallon Capital Management's 13F filing for Q1 2023, filed 15 May 2023.